Carcinoma in situ of rectosigmoid junction
ICD-10 D01.1 is a billable code used to indicate a diagnosis of carcinoma in situ of rectosigmoid junction.
Carcinoma in situ (CIS) of the rectosigmoid junction is a localized form of cancer characterized by the presence of abnormal cells that have not invaded surrounding tissues. This condition is often detected during screening procedures such as colonoscopy, where polyps or lesions may be biopsied. The rectosigmoid junction is the area where the rectum meets the sigmoid colon, making it a critical site for colorectal cancer screening. CIS is considered an early stage of cancer, and while it is not yet invasive, it has the potential to progress to invasive carcinoma if left untreated. Surveillance protocols typically involve regular colonoscopic examinations to monitor for any changes in the lesions, as well as potential surgical intervention to remove the affected area. The risk of progression to invasive cancer varies, but factors such as the size of the lesion, histological features, and patient demographics can influence this risk. Early detection and management are crucial to prevent progression and improve patient outcomes.
Detailed reports of colonoscopy findings, biopsy results, and treatment plans.
Routine screening colonoscopies, follow-up for previously diagnosed lesions, and management of patients with a family history of colorectal cancer.
Documentation must clearly indicate the nature of the lesion and any interventions performed.
Comprehensive treatment plans, including surgical notes and pathology reports.
Management of patients post-diagnosis of carcinoma in situ, including discussions of surgical options and surveillance strategies.
Coordination with pathology for accurate staging and grading of lesions.
Used for routine screening or follow-up of known lesions.
Document findings, any biopsies taken, and patient history.
Gastroenterologists must ensure accurate reporting of findings.
Carcinoma in situ is an early form of cancer that has not invaded surrounding tissues. It is crucial to detect and manage it early to prevent progression to invasive cancer.
